Peripheral delta opioid receptors require priming for functional competence in vivo

European Journal of Pharmacology

Volumn 602, Issue 2-3, 2009, Pages 283-287

  Rowan, Matthew P ^a   Ruparel, Nikita B ^a   Patwardhan, Amol M ^b   Berg, Kelly A ^a   Clarke, William P ^a   Hargreaves, Kenneth M ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Allodynia; Bradykinin; DPDPE; Hindpaw; Prostaglandin

Indexed keywords

ARACHIDONIC ACID; BISINDOLYLMALEIMIDE; BRADYKININ; CHELERYTHRINE; DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRINDOLE; OPIATE DERIVATIVE; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEINASE ACTIVATED RECEPTOR 2;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; ARACHIDONIC ACID; BRADYKININ; DINOPROSTONE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; PERIPHERAL NERVOUS SYSTEM; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 58149159544     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.028     Document Type: Article

References (28)

1. Berg K.A., Patwardhan A.M., Sanchez T.A., Silva Y.M., Hargreaves K.M., and Clarke W.P. Rapid modulation of μ-opioid receptor signaling in primary sensory neurons. J. Pharmacol. Exp. Ther. 321 (2007) 839-847
2. Berg K.A., Zardeneta G., Hargreaves K.M., Clarke W.P., and Milam S.B. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neurosci 144 (2007) 889-897
3. Blaukat A. Structure and signaling pathways of kinin receptors. Andrologia 35 (2003) 17-23
4. Cabot P.J. Immune-derived opioids and peripheral antinociception. Clin. Exp. Pharmacol. Physiol 28 (2001) 230-232
5. Carruthers A.M., Sellers L.A., Jenkins D.W., Jarvie E.M., Fenuik W., and Humphrey P.P.A. Adenosine A1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol. Pharmacol 59 (2001) 1533-1541
6. Caterina M.J., and Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Ann. Rev. Neurosci 24 (2001) 487-517
7. Catheline G., Kayser V., and Guilbaud G. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors. Eur. J. Pharmacol 315 (1996) 135-143
8. Cesare P., Dekker L.V., Sardini A., Parker P.J., and McNaughton P.A. Specific involvement of PKC-ε in sensitization of the neuronal response to painful heat. Neuron 23 (1999) 617-624
9. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., and Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J. Neurosci. Meth 76 (1997) 183-191
10. Endres-Becker J., Heppenstall P.A., Mousa S.A., Labuz D., Oksche A., Schafer M., Stein C., and Zollner C. μ-Opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol. Pharmacol 71 (2007) 12-18
11. Ferreira S.H., and Nakamura M. Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 18 (1979) 191-200
12. Gupta A., Bodin L., Holmstrom B., and Berggren L. A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth. Analg 93 (2001) 761-770
13. Hargreaves K.M., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
14. Hong Y., and Abbott F.V. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmacol 277 (1995) 21-28
15. Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., and Malan T.P. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. U.S.A 102 (2005) 3093-3098
16. Ingram S.L., and Williams J.T. Opioid inhibition of Ih via adenylyl cyclase. Neuron 13 (1994) 179-186
17. Joris J.L., Dubner R., and Hargreaves K.M. Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation?. Anesth. Analg 66 (1987) 1277-1281
18. Keita H., Kayser V., and Guilbaud G. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur. J. Pharmacol 277 (1995) 275-280
19. Ko M.C., Tuchman J.E., Johnson M.D., Wiesenauer K., and Woods J.H. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats. Psychopharmacol 148 (2000) 180-185
20. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., and Zuraw B.L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev 57 (2005) 27-77
21. Levine J.D., and Taiwo Y.O. Involvement of the mu-opiate receptor in peripheral analgesia. Neurosci 32 (1989) 571-575
22. Patwardhan A.M., Berg K.A., Akopian A.N., Jeske N.A., Gamper N., Clarke W.P., and Hargreaves K.M. Bradykinin-induced functional competence and trafficking of the δ-opioid receptor in trigeminal nociceptors. J. Neurosci 25 (2005) 8825-8832
23. Patwardhan A.M., Diogenes A., Berg K.A., Fehrenbacher J.C., Clarke W.P., Akopian A.N., and Hargreaves K.M. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125 (2006) 114-124
24. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429 (2001) 79-91
25. Souza A.L.S., Moreira F.A., Almeida K.R., Bertollo C.M., Costa K.A., and Coelho M.M. In vivo evidence for a role of protein kinase C in peripheral nociceptive processing. Br. J. Pharmacol 135 (2002) 239-247
26. Stein C., Machelska H., Binder W., and Schafer M. Peripheral opioid analgesia. Cuur. Opin. Pharmacol 1 (2001) 62-65
27. Stein C., Millan M.J., Shippenberg T.S., Peter K., and Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta, and kappa receptors. J. Pharmacol. Exp. Ther 248 (1989) 1269-1275
28. Stein C., Shafer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med 9 (2003) 1003-1008